Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma

被引:78
作者
Yoshimura, Mariko [1 ]
Ishizawa, Jo [2 ]
Ruvolo, Vivian [2 ]
Dilip, Archana [2 ]
Quintas-Cardama, Alfonso [2 ]
McDonnell, Timothy J. [3 ]
Neelapu, Sattva S. [4 ]
Kwak, Larry W. [4 ]
Shacham, Sharon [5 ]
Kauffman, Michael [5 ]
Tabe, Yoko [6 ]
Yokoo, Masako [1 ]
Kimura, Shinya [1 ]
Andreeff, Michael [2 ]
Kojima, Kensuke [1 ,2 ]
机构
[1] Saga Univ, Dept Med, Saga 8498501, Japan
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[5] Karyopharm Therapeut, Boston, MA USA
[6] Juntendo Univ, Sch Med, Dept Clin Lab Med, Tokyo 113, Japan
基金
美国国家卫生研究院;
关键词
Apoptosis; KPT-SINE; mantle cell lymphoma; p53; XPO1; CHRONIC LYMPHOCYTIC-LEUKEMIA; NUCLEAR EXPORT; SELECTIVE INHIBITORS; TP53; MUTATION; CANCER-CELLS; P53; CRM1; EXPRESSION; TUMOR; MDM2;
D O I
10.1111/cas.12430
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The nuclear transporter exportin-1 (XPO1) is highly expressed in mantle cell lymphoma (MCL) cells, and is believed to be associated with the pathogenesis of this disease. XPO1-selective inhibitors of nuclear export (SINE) compounds have been shown to induce apoptosis in MCL cells. Given that p53 is a cargo protein of XPO1, we sought to determine the significance of p53 activation through XPO1 inhibition in SINE-induced apoptosis of MCL cells. We investigated the prognostic impact of XPO1 expression in MCL cells using Oncomine analysis. The significance of p53 mutational/functional status on sensitivity to XPO1 inhibition in cell models and primary MCL samples, and the functional role of p53-mediated apoptosis signaling, were also examined. Increased XPO1 expression was associated with poor prognosis in MCL patients. The XPO1 inhibitor KPT-185 induced apoptosis in MCL cells through p53-dependent and -independent mechanisms, and p53 status was a critical determinant of its apoptosis induction. The KPT-185-induced, p53-mediated apoptosis in the MCL cells occurred in a transcription-dependent manner. Exportin-1 appears to influence patient survival in MCL, and the SINE XPO1 antagonist KPT-185 effectively activates p53-mediated transcription and apoptosis, which would provide a novel strategy for the therapy of MCL.
引用
收藏
页码:795 / 801
页数:7
相关论文
共 40 条
[31]   EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS [J].
Shen, Aiguo ;
Wang, Yuchan ;
Zhao, Yueming ;
Zou, Lin ;
Sun, Linlin ;
Cheng, Chun .
NEUROSURGERY, 2009, 65 (01) :153-160
[32]   CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications [J].
Tai, Y-T ;
Landesman, Y. ;
Acharya, C. ;
Calle, Y. ;
Zhong, M. Y. ;
Cea, M. ;
Tannenbaum, D. ;
Cagnetta, A. ;
Reagan, M. ;
Munshi, A. A. ;
Senapedis, W. ;
Saint-Martin, J-R ;
Kashyap, T. ;
Shacham, S. ;
Kauffman, M. ;
Gu, Y. ;
Ghobrial, I. ;
Zhan, F. ;
Kung, A. L. ;
Schey, S. A. ;
Richardson, P. ;
Munshi, N. C. ;
Anderson, K. C. .
LEUKEMIA, 2014, 28 (01) :155-165
[33]   Nuclear export of proteins and drug resistance in cancer [J].
Turner, Joel G. ;
Dawson, Jana ;
Sullivan, Daniel M. .
BIOCHEMICAL PHARMACOLOGY, 2012, 83 (08) :1021-1032
[34]   The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation [J].
Van der Watt, Pauline J. ;
Maske, Christopher P. ;
Hendricks, Denver T. ;
Parker, M. Iqbal ;
Denny, Lynette ;
Govender, Dhirendra ;
Birrer, Michael J. ;
Leaner, Virna D. .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (08) :1829-1840
[35]   The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells [J].
Vaseva, Angelina V. ;
Marchenko, Natalia D. ;
Moll, Ute M. .
CELL CYCLE, 2009, 8 (11) :1711-1719
[36]   In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 [J].
Vassilev, LT ;
Vu, BT ;
Graves, B ;
Carvajal, D ;
Podlaski, F ;
Filipovic, Z ;
Kong, N ;
Kammlott, U ;
Lukacs, C ;
Klein, C ;
Fotouhi, N ;
Liu, EA .
SCIENCE, 2004, 303 (5659) :844-848
[37]   A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species [J].
Verhaegen, Monique ;
Bauer, Joshua A. ;
de la Vega, Cristina Martin ;
Wang, Guoping ;
Wolter, Keith G. ;
Brenner, J. Chadwick ;
Nikolovska-Coleska, Zaneta ;
Bengtson, Audrey ;
Nair, Rajan ;
Elder, James T. ;
Van Brocklin, Matt ;
Carey, Thomas E. ;
Bradford, Carol R. ;
Wang, Shaomeng ;
Soengas, Maria S. .
CANCER RESEARCH, 2006, 66 (23) :11348-11359
[38]   NESdb: a database of NES-containing CRM1 cargoes [J].
Xu, Darui ;
Grishin, Nick V. ;
Chook, Yuh Min .
MOLECULAR BIOLOGY OF THE CELL, 2012, 23 (18) :3673-3676
[39]   The expression of CRM1 is associated with prognosis in human osteosarcoma [J].
Yao, Yang ;
Dong, Yang ;
Lin, Feng ;
Zhao, Hui ;
Shen, Zan ;
Chen, Ping ;
Sun, Yuan-Jue ;
Tang, Li-Na ;
Zheng, Shui-Er .
ONCOLOGY REPORTS, 2009, 21 (01) :229-235
[40]   Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma [J].
Zhang, Kejie ;
Wang, Michael ;
Tamayo, Archito T. ;
Shacham, Sharon ;
Kauffman, Michael ;
Lee, John ;
Zhang, Liang ;
Ou, Zhishuo ;
Li, Changping ;
Sun, Luhong ;
Ford, Richard J. ;
Pham, Lan V. .
EXPERIMENTAL HEMATOLOGY, 2013, 41 (01) :67-78